Skip to content

C3 Total Joint Patient Registry

Clinical Care Continuum (C3) Total Joint Patient Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02188199
Enrollment
10000
Registered
2014-07-11
Start date
2012-05-31
Completion date
Unknown
Last updated
2014-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Replacement, Knee Replacement

Keywords

Hip, Knee, Hip replacement, Knee replacement, Total Joint

Brief summary

This study will assess the efficacy of products, implants, and procedures for knee and hip replacement.

Detailed description

This registry will prospectively collect a core set of data on patients undergoing knee or hip replacement. This registry will include a variety of different products, implants, technologies and procedures. The registry will also collect any adverse events/complications that occur during or following these surgeries. This database can also be utilized in the future to answer research questions, by retrospectively going back through the data. This information also may go to insurance companies or hospitals for quality measurement and metrics reporting. The data will be utilized to develop strategic treatment pathways that will improve patient care. Ultimately, the goal of the registry is to enhance the understanding of treatment associated with knee and hip replacement and the resulting patient outcomes. The registry will also be used to provide quality measurement and metrics reporting.

Interventions

None listed

Sponsors

Clinical Care Continuum (C3) Foundation
CollaboratorUNKNOWN
National Research Independent Operations Management
CollaboratorOTHER
DC2 Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Undergoing knee or hip replacement * Subject is likely to follow standard of care post-operative follow up for at least 1 year

Exclusion criteria

* Inability to complete follow-up visits or required questionnaires * Inability to provide informed consent without a legally authorized representative

Design outcomes

Primary

MeasureTime frameDescription
Change in Knee injury and Osteoarthritis Outcome Score (KOOS) from baseline at 6 monthsbaseline and 6 monthsAssessment of knee symptoms and disability to be taken at baseline and 6 months after surgery
Change in Hip disability and Osteoarthritis Outcome Score (HOOS) from baseline at 3 monthsbaseline and 3 monthsAssessment of hip symptoms and disability to be taken at baseline and 3 months after surgery
Change in Hip disability and Osteoarthritis Outcome Score (HOOS) from baseline at 6 monthsbaseline and 6 monthsAssessment of hip symptoms and disability to be taken at baseline and 6 months after surgery
Change in Hip disability and Osteoarthritis Outcome Score (HOOS) from baseline at 1 yearbaseline and 1 yearAssessment of hip symptoms and disability to be taken at baseline and 1 year after surgery
Change in Knee injury and Osteoarthritis Outcome Score (KOOS) from baseline at 3 monthsbaseline and 3 monthsAssessment of knee symptoms and disability to be taken at baseline and 3 months after surgery
Change in Knee injury and Osteoarthritis Outcome Score (KOOS) from baseline at 1 yearbaseline and 1 yearAssessment of knee symptoms and disability to be taken at baseline and 1 year after surgery

Secondary

MeasureTime frameDescription
Adverse Events at 6 weeks after surgery6 weeks after surgerywithin 6 weeks but not less than 1 week after surgery
Adverse Events at 3 months after surgery3 months after surgery
Adverse Events at 6 months after surgery6 months after surgery
Adverse Events at 1 year after surgery1 year after surgery
Adverse Events at time of surgeryTime of surgery

Countries

United States

Contacts

Primary ContactChristina R Cook, PhD
ccook@dc2healthcare.com615-712-9574
Backup ContactRisa Tyo, PharmD
rtyo@dc2healthcare.com615-712-9574

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026